Chinese drug maker Sinopharm could get Phase III COVID-19 vaccine trials underway soon in Brazil.
That's following an agreement with Parana state, pending approval.
Patrick Fok reports.
IN: The deal to
OUT: 15-thousand volunteers.
DUR: 40 secs
LINK: LINK: http://fsnradionews.com/feeds/3007sinopharm.mp3
That's following an agreement with Parana state, pending approval.
Patrick Fok reports.
IN: The deal to
OUT: 15-thousand volunteers.
DUR: 40 secs
LINK: LINK: http://fsnradionews.com/feeds/3007sinopharm.mp3